Influenza virus vaccine (AlphaVax)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza virus vaccine (AlphaVax)
Drug Alias NameInfluenza virus vaccine甲病毒复制子疫苗甲型/怀俄明/03/2003梅毒 - AlphaVaxSeasonal influenza vaccine for elderlyAVX-502
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlphavax Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A